Frontline BioVentures
VC firm investing in early & growth stage tech & life sciences companies in Asia
About This Fund
Frontline BioVentures is an institutional investor (Conventional VCs) founded in 2012 and headquartered in Hong Kong, china. Frontline BioVentures is a venture capital firm that invests in early and growth stage companies in Asia. Invests in Tech and Life Sciences companies that are operating in sectors like Biopharma, Medical Devices, Diagnostics, HealthTech. Notable investments include Sinopharm, Innovent Biologics, Hua Medicine, Neusoft. Practice areas include Investment Industry. The firm operates as Venture Capital Funds. Key investment sectors include Healthcare / HealthTech and Biotech / Biopharma. The firm typically invests at the Growth stage(s). Geographic focus spans Asia. Notable portfolio companies: Sinopharm, Innovent Biologics, Hua Medicine, Neusoft.
Investment Focus
Preparing to pitch Frontline BioVentures?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →